223492-52-2

Basic information

• Product Name: Acetic acid, [3-[[[[4-(1,1-dimethylethyl)phenyl]methyl](3-pyridinylsulfonyl)amino]methyl ]phenoxy]-, 1,1-dimethylethyl ester
• CAS NO: 223492-52-2
• Molecular Formula: C29H36N2O5S
• Molecular Weight: 524.681
• Mol File: 223492-52-2.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: Acetic acid, [3-[[[[4-(1,1-dimethylethyl)phenyl]methyl](3-pyridinylsulfonyl)amino]methyl ]phenoxy]-, 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Acetic acid, [3-[[[[4-(1,1-dimethylethyl)phenyl]methyl](3-pyridinylsulfonyl)amino]methyl ]phenoxy]-, 1,1-dimethylethyl ester(223492-52-2)
• EPA Substance Registry System: Acetic acid, [3-[[[[4-(1,1-dimethylethyl)phenyl]methyl](3-pyridinylsulfonyl)amino]methyl ]phenoxy]-, 1,1-dimethylethyl ester(223492-52-2)

Safety Data

• Hazardous Substances Data: 223492-52-2(Hazardous Substances Data)

Upstream product

• 223492-51-1 {3-[(4-tert-butyl-benzylamino)-methyl]-phenoxy}acetic acid tert-butyl ester 
• 42899-76-3 pyridine-3-sulfonyl chloride hydrochloride 

Downstream Products

• 223488-57-1 (3-(((4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino)-methyl)-phenoxy)-acetic acid 

Relevant articles and documents

Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and an EP2 or EP4 selective agonist

The present invention relates to pharmaceutical compositions and methods of treatment comprising administering to a patient in need thereof a combination of a 2-alkylidene-19-nor-vitamin D derivative and an EP2 or EP4 selective agonist or a pharmaceutically acceptable salt or prodrug thereof. Particularly, the present invention relates to pharmaceutical compositions and methods comprising administering to a patient in need thereof 2-methylene-19-nor-20(S)-1α,25-dihydroxyvitamin D3 and an EP2 or EP4 selective agonist or a pharmaceutically acceptable salt or prodrug thereof.